OpenAI CEO Sam Altman took the technology world by surprise on Thursday with the release of Operator, his company's first AI agent that can act

DeepSeek’s latest models, created by a small company with limited resources, are already beating many of the leading AI models in the United States.

Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin studies this year.

DeepSeek R1, the surprisingly efficient and powerful Chinese AI model, has taken the technology industry by storm and is rattling nerves on Wall Street.

Since then, Musk hasn’t hidden his anger with Altman and OpenAI. He’s currently suing the company over its decision to become a for-profit corporation, and he regularly trolls the company on X—the platform he bought for $44 billion back in 2022. All of which is why the past week has been hilarious.

OpenAI CEO Sam Altman will brief U.S. officials on super-agents—AI systems set to revolutionize software development, finance, and event planning.

Loti, a 'likeness protection company,' uses AI to take down deepfakes and voice clones of actors, musicians, politicians and other public figures.

Retro Biosciences Inc., a startup using artificial intelligence to discover new drugs, is reportedly raising $1 billion in funding to support its research. The Financial Times today cited sources as saying that Sam Altman is participating in the investment. He previously provided the initial $180 million funding round that helped launch Retro.

Elon Musk is clashing with OpenAI CEO Sam Altman over the Stargate artificial intelligence infrastructure project touted by President Donald Trump, the latest in a feud between the two billionaires that started on OpenAI’s board and is now testing

President Donald Trump spoke with OpenAI CEO Sam Altman by phone Friday, ahead of the AI infrastructure announcement, CNBC has learned.

Impact Link Over the years, OpenAI CEO Sam Altman has shared predictions about where he thinks we're headed on artificial general intelligence, superintelligence, agentic AI, and more — and when ...